SCHEMBL874465

SCHEMBL874465

O=C(O)Cc1cncs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16892250 0.81
SCHEMBL954216 0.81
SCHEMBL2517712 0.79 FFAR1 (0.49)
SCHEMBL28109155 0.78 PARP15 (0.43)
SCHEMBL16887640 0.78 RAB9A (0.40)
SCHEMBL13851671 0.76 FFAR1 (0.43)
SCHEMBL16886384 0.76 RAB9A (0.39)
SCHEMBL4095559 0.74 SMN1; SMN2 (0.54)
SCHEMBL19475116 0.72 RAB9A (0.40)
SCHEMBL9367356 0.71 SLC6A3 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107857740-A The synthetic method of the thiazolyl acetic acid of 2 sulfydryl of Cefodizime Sodium intermediate, 4 methyl 5 山东金城医药化工有限公司 2018-03-30 CN claimed
CN-102648199-A Piperidine compound and use thereof ASTRAZENECA AB 2012-08-22 CN claimed
JP-2007522178-A 2007-08-09 JP claimed
EP-1740568-A2 BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL FOR THE TREATMENT OF CARDIOVASCULAR DISEASE. SMITHKLINE BEECHAM CORPORATION (US) 2007-01-10 EP claimed
WO-2005077926-A2 BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL FOR THE TREATMENT OF CARDIOVASCULAR DISEASE SMITHKLINE BEECHAM CORPORATION (US) 2005-08-25 WO claimed
US-12559462-B2 Pyrimidine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2026-02-24 US disclosed
US-20250368614-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2025-12-04 US disclosed
EP-4654969-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2025-12-03 EP disclosed
US-20250270172-A1 Pyrimidine Derivatives As Modulators of the 5-HT2A Serotonin Receptor Useful For The Treatment of Disorders Related Thereto ARENA PHARMACEUTICALS, INC. (US) 2025-08-28 US disclosed
EP-4236937-B1 PYRIMIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2025-07-23 EP disclosed
WO-2024159067-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2024-08-02 WO disclosed
US-20230157952-A1 METHOD FOR IMPROVING THE STABILITY OF A PHARMACEUTICAL COMPOSITION COMPRISING A HIGH PENETRATION DRUG, AND THE PHARMACEUTICAL COMPOSITION OBTAINED THEREFROM TECHFIELDS INC. (US) 2023-05-25 US disclosed
EP-0159899-A2 Cephalosporin esters, their production and use Takeda Chemical Industries, Ltd. (JP) 1985-10-30 EP disclosed
EP-0137403-A2 Carbapenems, their production and use Takeda Chemical Industries, Ltd. (JP) 1985-04-17 EP disclosed
EP-0037710-B1 THIAZOLE DERIVATIVES JOHN WYETH &amp; BROTHER LIMITED (GB) 1984-08-01 EP disclosed
US-4385059-A 4-(4-CHLOROPHENYL)-2-(4-HYDROXYPHENYL)THIAZOLE-5-ACETIC ACID JOHN WYETH AND BROTHER LIMITED (GB) 1983-05-24 US disclosed
US-4356185-A ANTIINFLAMMATORY AGENTS JOHN WYETH & BROTHER LIMITED (GB) 1982-10-26 US disclosed
EP-0037710-A1 Thiazole derivatives JOHN WYETH &amp; BROTHER LIMITED (GB) 1981-10-14 EP disclosed
US-4203896-A WITH MERCURIC ACETATE AND ACETIC ACID, ACIDIC HYDROLYSIS OF N-PROPENYL GROUP ELI LILLY AND COMPANY (US) 1980-05-20 US disclosed
US-4144232-A Substituted azetidin-2-one antibiotics ELI LILLY AND COMPANY (US) 1979-03-13 US disclosed